Oscar Health (OSCR) Tumbles 8% on Lack of Catalysts

We recently published 10 Stocks Crash as AI Glow Fades. Oscar Health, Inc. (NYSE:OSCR) is one of Wednesday’s worst performers.

Oscar Health dropped its share prices by 8.18 percent on Wednesday to close at $15.27 apiece as investors unloaded positions amid the overall market pessimism while waiting for fresh catalysts to spark buying appetite.

Last week, Oscar Health, Inc. (NYSE:OSCR) teamed up with Hy-Vee Health for the launch of a new employer-backed insurance product called “Hy-Vee Health with Oscar” in Des Moines, Iowa.

The product, which supports the individual coverage health reimbursement arrangements (ICHRA), allows individuals and employees to choose their preferred health insurance packages and have them paid by their employers.

According to Oscar Health, Inc. (NYSE:OSCR), the plan is available to 400,000 employees in greater Des Moines through their employer on the individual marketplace starting Nov. 1, 2025, for coverage effective Jan. 1, 2026.

“We are shaping the future of healthcare for consumers and employers. Everyone deserves healthcare that is affordable, convenient, and simple. Our partnership reflects the innovation we are driving in the individual market to exceed expectations across the country,” said Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini.

While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.